Symbol="CRMD"
AssetType="Common Stock"
Name="CorMedix Inc"
Description="CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1410098"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="745 ROUTE 202-206, SUITE 303, BRIDGEWATER, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="216270000"
EBITDA="-38094832"
PERatio="None"
PEGRatio="0"
BookValue="1.071"
DividendPerShare="0"
DividendYield="0"
EPS="-0.8"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-1045.29"
ReturnOnAssetsTTM="-0.382"
ReturnOnEquityTTM="-0.666"
RevenueTTM="36520"
GrossProfitTTM="61670"
DilutedEPSTTM="-0.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.473"
AnalystTargetPrice="13.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1837.69"
PriceToBookRatio="2.771"
EVToRevenue="1062.73"
EVToEBITDA="-3.288"
Beta="1.833"
num_52WeekHigh="6.09"
num_52WeekLow="2.71"
num_50DayMovingAverage="4.397"
num_200DayMovingAverage="4.289"
SharesOutstanding="45377800"
DividendDate="2019-03-26"
ExDividendDate="None"
symbol="CRMD"
open="4.05"
high="4.15"
low="3.97"
price="4.09"
volume="306362.00"
latest_trading_day="2023-08-18"
previous_close="4.10"
change="-0.01"
change_percent="-0.2439%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="41"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="604139"
Change_recent_avg="0.01"
Delta_recent_avg="0.29"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_negative_thumbnail_id_2="1163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="964"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
